| Hypertension |
1 |
1 |
| Blood |
0 |
0.78 |
| Antihypertensive Agents |
0 |
0.52 |
| Myocardial Infarction (MI) |
0 |
0.46 |
| Cardiovascular Risk Management |
0 |
0.8 |
| Patient Safety |
0 |
0.17 |
| Heart |
0 |
0.16 |
| Hospital |
0 |
0.16 |
| Cerebrovascular Accident |
0 |
0.14 |
| Fractures |
0 |
0.14 |
| Adherence |
0 |
0.1 |
| Chronotherapy |
0 |
0.1 |
| Clinical Pharmacology |
0 |
0.1 |
| Pharmacoepidemiology |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Sleep Apnea |
0 |
0.07 |
| Sleep Disorders |
0 |
0.07 |
| Tobacco Cessation |
0 |
0.07 |
| Adverse Effects |
0 |
0.05 |
| California |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| Circadian Rhythm |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Dizziness |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Hypotension |
0 |
0.05 |
| Infarction |
0 |
0.05 |
| Internet |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Sleep |
0 |
0.05 |
| Smoking |
0 |
0.05 |
| Spain |
0 |
0.05 |